Skip to content
Saturday, November 23, 2024
Latest:
  • Compassion beyond hospital curtains and prison bars 
  • FROM THE LABS: From bench to bedside: Osteoarthritis gene therapy developed in the lab at Baylor is in clinical trials nationwide
  • The dangers of vaping
  • Thanksgiving nutrition: enjoying holiday favorites while staying on track with your health goals
  • How tau becomes a ‘bad guy’ that contributes to Alzheimer’s disease
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor D. Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

chemotherapy resistance

Two slides showing breast cancer cells as blue or green dots on a blue background.
From The Labs

Research reveals markers of chemotherapy resistance and outcome in triple negative breast cancer

September 6, 2022 chemotherapy resistance,  microscaled proteogenomics,  Research,  triple-negative breast cancer

The findings help predict tumor response so that only effective treatments are given.

Read More

From the Labs: Image of the Month

Overexpression of lamin A (red) causes structural changes to the cell nucleus that are associated with aging. From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951